EU extends GMP, GDP certificates through 2022 as pandemic effects linger
Regulatory NewsMichael Mezher
APIsBiologics/ biosimilars/ vaccinesBiotechnologyEuropePharmaceuticalsProduct LifecycleRegulatory NewsMichael MezherAPIsBiologics/ biosimilars/ vaccinesBiotechnologyEuropePharmaceuticalsProduct Lifecycle